Prostate Cancer Therapy: Supporting Strategies and Management Options

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 161

Special Issue Editors


E-Mail Website
Guest Editor
Department of Urology, University Medicine Greifswald, 17475 Greifswald, Germany
Interests: urological oncology; urological surgery; robot-assisted surgery

E-Mail Website
Guest Editor
Department of Urology, St. Elisabeth Hospital Straubing, 94315 Straubing, Germany
Interests: bladder cancer; prostate cancer; renal cell carcinoma; robot-assisted surgery; biomarker-based oncology studies; prognostic outcome models; translational research, multicenter projects in genitourinary oncology research

Special Issue Information

Dear Colleagues,

Prostate cancer (PCa) stands as one of the most prevalent cancers affecting men globally. As with any malignancy, early detection, pre-treatment preparation and prehabilitation, and effective disease management are paramount in determining favorable patient outcomes.

We are excited to announce our upcoming Special Issue, aiming to provide a comprehensive overview of the current landscape of PCa treatment. It will particularly focus on supportive measures and diverse management options, serving as a vital resource for researchers, practitioners and clinicians in this field.

Within this Special Issue, we have specific interest in articles that delve into supportive measures. These may include investigations into lifestyle modifications, dietary interventions, physical activity or exercise regimens, and risk reduction techniques that have the potential to mitigate the risk of progression or enhance therapeutic responses. We believe that an interdisciplinary approach involving not only urologists and oncologists, but also nutritionists, exercise physiologists and public health professionals is crucial in this endeavor. Moreover, we welcome contributions that address the latest advancements, challenges and emerging approaches in the field of PCa therapy aiming to prevent the progression of initially localized PCa to more advanced stages. This Special Issue will serve as a platform for the exchange of innovative ideas and the dissemination of critical research findings, ultimately promoting progress in the understanding and treatment of PCa.

To ensure that this Special Issue becomes a comprehensive and authoritative resource, we are inviting submissions of original research and reviews. We are eager to receive your contributions and await your insightful research on PCa therapy and supportive strategies. Your expertise and dedication are crucial in advancing our collective knowledge in this critical area of medicine. We sincerely appreciate your commitment to advancing PCa research and patient care. We are confident that your contributions will significantly enhance the value of this Special Issue for the medical community.

Dr. Ingmar Wolff
Prof. Dr. Matthias May
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • prostate cancer
  • therapy
  • supporting strategies
  • management options
  • lifestyle modifications
  • dietary interventions
  • risk reduction techniques
  • prehabilitation
  • physical activity
  • interdisciplinary approach
  • cancer early detection strategies
  • rehabilitation
  • complications

Published Papers

This special issue is now open for submission, see below for planned papers.

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Title: Long-term Follow-up of Peritoneal Interposition Flap in Symptomatic Lymphocele Reduction Following Robot-Assisted Radical Prostatectomy: Insights from the PIANOFORTE Trial
Authors: Christopher Gossler; Matthias May; Steffen Weikert; Sebastian Lenart; Anton Ponholzer; Christina Dreissig; Gjoko Stojanoski; Isabel Anzinger; Josef Riester; Maximilian Burger; Christian Gilfrich; Roman Mayr; Johannes Bründl
Affiliation: Department of Urology, St. Elisabeth Hospital Straubing, 94315 Straubing, Germany
Abstract: /

Back to TopTop